GlobalData: Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017 on reports-research.com

GlobalData, the industry analysis specialist, has released its new report, Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Influenza Vaccines market. The report identifies the key trends shaping and driving the global Influenza Vaccines market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global Influenza Vaccines sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

GlobalData estimated the global influenza vaccines market to be worth $2.8 billion in 2009. It is forecast to grow at a CAGR of 8% to reach $5 billion by 2017. This high growth forecast is primarily attributed to an increase in the patient population as a result of the increasing world population, and the need to get vaccinated each year. This growth will be further supported by increased production capacities of companies to cater to the rising demand. The strong product pipeline will complement the existing products by providing effective treatment options.

The Influenza Vaccines Market is Forecast to Show Increased Growth until 2017

GlobalData estimated the global influenza vaccines market to be worth $2.8 billion in 2009. It is forecast to grow at a CAGR of 8% to reach $5 billion by 2017. This high growth forecast is primarily attributed to an increase in the patient population as a result of the increasing world population, and the need to get vaccinated each year. This growth will be further supported by increased production capacities of companies to cater to the rising demand. The strong product pipeline will complement the existing products by providing effective treatment options.

Current Vaccination Options are Highly Successful in Meeting Market Demand

GlobalData found that the products currently in the market are highly efficacious in providing protection against the disease with minimum side-effects. All the marketed products provide high seroprotection rates and seroconversion rates against the disease. The key products such as Fluzone, Fluvirin, Fluarix, FluLaval and Flumist are able to satisfy the demand in the influenza vaccines market. The unmet need arises from the fact that vaccination against one strain of the virus may not provide protection against other strains of the influenza virus. More importantly, the virus strains change every year, and so people have to get themselves vaccinated each year.

Unmet Need in the Influenza Vaccines Market is Low, Mostly Associated with Niche Segments

The influenza vaccines market has very low unmet needs as the market is very well served by the current product options. This leaves little scope for new entrants to capture value from under-served segments. The new products have to aim at getting market share by providing unique offerings and targeting niche segments. The likely under-served segments are elderly populations and people allergic to egg-based vaccines. The current pipeline, however, is strong enough to cater to this unmet need.

Strong Pipeline Candidates Will Encourage Competition in the Influenza Vaccines Market

GlobalData found that the product pipeline for influenza vaccines is strong with 93 molecules in various phases of clinical development. There are seven molecules in Phase III, 27 in Phase II and 26 molecules undergoing Phase I clinical trials. These vaccines are as safe and efficacious as the currently marketed ones with novel development procedure or routes of administration. They target the small unmet need that exists in the market. They will compete with the well established marketed vaccines and are likely to redefine the competitive landscape in the market.

GlobalData: Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017:
http://www.reports-research.com/market-surveys/influenza-vaccines-pipeline-assessment-market-forecasts-2017-p-65943.html

GlobalData: More market data and market reports:
http://www.reports-research.com/market-surveys/globaldata-m-304.html

markt-studie.de founded in 2002 has emerged as a leading online portal for market surveys and market research in German speaking areas. Four years later the English language portal reports-research.com was introduced due to the extraordinary success of the portal. Again one year later estudio-mercado.es - the Spanish spoken portal - was founded. The objective of the three portals is to competently and efficiently support consultants and decision makers in management, sales and marketing in the search for worldwide market research. Prospective buyers can look into more than 60,000 market surveys from more than 200 international publishers, current market data for more than 6,000 branches worldwide, 10,000 company profiles as well as a free-of-charge research and recommendation service for individual market research.

reports-research.com
c/o dynamic technologies GmbH
Siegburger Str. 233
50679 Köln
Germany

Manuel Bravo Sanchez (CEO)

info@reports-research.com
or
Tel ++49 (0)221 677 897 32
Fax ++49 (0)221 677 897 34

This release was published on openPR.